Skip to content

Clinical trials

Phase 3 Substance-Related Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 3 Country / region: United States Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20021
20033
20047
20053
20063
20071
20082
20093
20103
20111
20121
20132
20141
20151
20171
20181
20191
20202
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Withdrawn2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University5
Johns Hopkins University4
Butler Hospital3
Chestnut Health Systems3
Dartmouth-Hitchcock Medical Center3
Boston Medical Center2
Brigham and Women's Hospital2
University of Cincinnati2
University of Miami2
Alcohol Research Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders51
Opioid-Related Disorders13
HIV Infections6
Alcoholism4
Mental Disorders3
Stress Disorders, Post-Traumatic3
Anxiety Disorders2
Bipolar Disorder2
Chemically-Induced Disorders2
Cocaine-Related Disorders2

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.